- Home
- STRO vs MVST Comparison
STRO vs MVST Comparison
Compare STRO & MVST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRO
- MVST
- Stock Information
- Founded
- STRO 2003
- MVST 2006
- Country
- STRO United States
- MVST United States
- Employees
- STRO N/A
- MVST N/A
- Industry
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- MVST Industrial Machinery/Components
- Sector
- STRO Health Care
- MVST Miscellaneous
- Exchange
- STRO Nasdaq
- MVST Nasdaq
- Market Cap
- STRO 172.8M
- MVST 182.8M
- IPO Year
- STRO 2018
- MVST N/A
- Fundamental
- Price
- STRO $2.06
- MVST $1.12
- Analyst Decision
- STRO Strong Buy
- MVST Buy
- Analyst Count
- STRO 7
- MVST 3
- Target Price
- STRO $12.14
- MVST $3.33
- AVG Volume (30 Days)
- STRO 1.4M
- MVST 17.2M
- Earning Date
- STRO 11-13-2024
- MVST 11-12-2024
- Dividend Yield
- STRO N/A
- MVST N/A
- EPS Growth
- STRO N/A
- MVST N/A
- EPS
- STRO N/A
- MVST N/A
- Revenue
- STRO $160,955,000.00
- MVST $370,989,000.00
- Revenue This Year
- STRO N/A
- MVST $19.19
- Revenue Next Year
- STRO N/A
- MVST $29.35
- P/E Ratio
- STRO N/A
- MVST N/A
- Revenue Growth
- STRO 230.90
- MVST 39.03
- 52 Week Low
- STRO $2.04
- MVST $0.15
- 52 Week High
- STRO $6.13
- MVST $1.95
- Technical
- Relative Strength Index (RSI)
- STRO 27.92
- MVST 59.82
- Support Level
- STRO $2.03
- MVST $1.15
- Resistance Level
- STRO $3.01
- MVST $1.38
- Average True Range (ATR)
- STRO 0.18
- MVST 0.26
- MACD
- STRO -0.04
- MVST -0.02
- Stochastic Oscillator
- STRO 2.55
- MVST 30.83
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers.
About MVST Microvast Holdings Inc.
Microvast Holdings Inc is a technology innovator that designs, develops, and manufactures lithium-ion battery solutions. It is renowned for its cutting-edge cell technology and its vertical integration capabilities which extend from core battery chemistry to battery packs.